Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-9656347

RESUMEN

Forty-four cases of pulmonary paragonimiasis, two also with evidence of cerebral infection, were found in Sin Ho District in Northern Viet Nam. There were 30 males and 14 females, 2-30 years of age. The diagnosis was made by sputum examination. Pet dogs and wild dogs in the area were also found infected and the people often eat roasted crabs.


Asunto(s)
Paragonimiasis/epidemiología , Adolescente , Adulto , Animales , Antiplatelmínticos/uso terapéutico , Encefalopatías/tratamiento farmacológico , Encefalopatías/parasitología , Niño , Preescolar , Enfermedades de los Perros/epidemiología , Perros , Etnicidad , Femenino , Humanos , Lactante , Enfermedades Pulmonares Parasitarias/tratamiento farmacológico , Enfermedades Pulmonares Parasitarias/epidemiología , Masculino , Paragonimiasis/tratamiento farmacológico , Paragonimiasis/veterinaria , Praziquantel/uso terapéutico , Población Rural , Vietnam/epidemiología , Vietnam/etnología
2.
Immunol Lett ; 23(1): 61-4, 1989 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-2558072

RESUMEN

The basal and stimulated intracellular cyclic AMP (cAMP) levels of peripheral blood mononuclear cells (PBMC) of 16 control subjects and 14 patients with systemic lupus erythematosus (SLE), all fulfilling the ARA criteria, were studied. No significant difference in basal cAMP level was observed between SLE patients and controls. SLE lymphocytes (both active and inactive) elicited a diminished response to aminophylline and prostaglandin E2 (PGE2). No correlation was seen between disease activity and either baseline cAMP levels or response to these stimulators. We suggest an intrinsic (not disease activity-related) impairment of the adenylate cyclase-dependent regulatory mechanism in the PBMC of SLE patients, which may result in a defective IL-2 production and IL-2 dependent biological functions.


Asunto(s)
AMP Cíclico/sangre , Lupus Eritematoso Sistémico/sangre , Linfocitos/metabolismo , Aminofilina/farmacología , Dinoprostona/farmacología , Humanos , Técnicas In Vitro , Interleucina-2/biosíntesis , Linfocitos/efectos de los fármacos , Linfocitos/inmunología
3.
J Clin Lab Immunol ; 30(1): 41-4, 1989 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-2484315

RESUMEN

We developed a sensitive bioassay system for the determination of tumor necrosis factor-alpha (TNF) using HEp-2 adherent human epipharynx carcinoma cells as targets. TNF from separated human monocytes was triggered by lipopolysaccharide (LPS). In a 24 hr 3H-thymidine incorporation assay, TNF-like activity was seen to reproducibly destroy radiolabeled target cells, i.e., inhibits thymidine incorporation and causes detachment of adherent HEp-2 cells. HEp-2 cells were insensitive to human interleukin-1 (IL-1) and interleukin-2 (IL-2). In contrast, human interferon-alpha and gamma were also cytotoxic for target cells. Monocyte supernatants stimulated by LPS, however, failed to contain detectable amounts of interferons.


Asunto(s)
Bioensayo/métodos , Células Tumorales Cultivadas/efectos de los fármacos , Factor de Necrosis Tumoral alfa/análisis , Carcinoma de Células Escamosas/patología , Humanos , Interferones/análisis , Interferones/farmacología , Interleucinas/farmacología , Neoplasias Laríngeas/patología , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/metabolismo , Lipopolisacáridos/farmacología , Activación de Linfocitos , Proteínas Recombinantes/farmacología , Factor de Necrosis Tumoral alfa/metabolismo
4.
Acta Med Hung ; 46(4): 245-52, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2636360

RESUMEN

Interleukin-1 and tumour necrosis factor-alpha activity by E. coli lipopolysaccharide-triggered monocytes was studied in patients with systemic lupus erythematosus in various stages of activity. Monocytes from both groups of SLE patients produced significantly less tumour necrosis factor-alpha activity than those of age and sex matched healthy controls. However, interleukin-1 activity was only significantly reduced in patients with active stage of the disease. These findings indicate further immunoregulatory disturbances in monocyte function concerning SLE.


Asunto(s)
Interleucina-1/sangre , Lupus Eritematoso Sistémico/inmunología , Monocitos/inmunología , Factor de Necrosis Tumoral alfa/biosíntesis , Adulto , Bioensayo , Células Cultivadas , Femenino , Humanos , Interleucina-1/biosíntesis , Lipopolisacáridos/farmacología , Lupus Eritematoso Sistémico/sangre , Masculino , Monocitos/efectos de los fármacos , Valores de Referencia
5.
Clin Rheumatol ; 7(4): 514-9, 1988 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-3246135

RESUMEN

Patients with Sjögren's syndrome were treated with vitamin A (100,000 U) daily during a two-week period. The vitamin treatment significantly elevated their ADCC and NK activity. The lymphocyte blast transformation, however was not noticeably changed. After the treatment, the retinyl-ester and retinol level of the plasma significantly increased as did the plasma level of vitamin E. The level of TBA reactive substances (malondialdehyde) in the plasma increased, whilst the glutathione peroxidase and catalase activity of erythrocytes decreased. The activity of the plasma glutathione peroxidase increased, but not significantly.


Asunto(s)
Peroxidación de Lípido/efectos de los fármacos , Síndrome de Sjögren/tratamiento farmacológico , Vitamina A/uso terapéutico , Citotoxicidad Celular Dependiente de Anticuerpos/efectos de los fármacos , Femenino , Humanos , Células Asesinas Naturales/efectos de los fármacos , Activación de Linfocitos/efectos de los fármacos , Malondialdehído/sangre , Persona de Mediana Edad , Síndrome de Sjögren/inmunología , Síndrome de Sjögren/metabolismo , Vitamina E/sangre
6.
J Clin Lab Immunol ; 26(1): 33-5, 1988 May.
Artículo en Inglés | MEDLINE | ID: mdl-3184159

RESUMEN

Treatment of patients suffering from systemic lupus erythematosus with vitamin A (100,000 U daily for 2 weeks) resulted in an enhancement of antibody-dependent cell-mediated cytotoxicity, natural killer cell activity and blastogenic response to plant mitogens and interleukin-2 (IL-2).


Asunto(s)
Inmunidad Celular/efectos de los fármacos , Lupus Eritematoso Sistémico/tratamiento farmacológico , Vitamina A/uso terapéutico , Adulto , Citotoxicidad Celular Dependiente de Anticuerpos/efectos de los fármacos , Femenino , Humanos , Técnicas In Vitro , Células Asesinas Naturales/efectos de los fármacos , Lupus Eritematoso Sistémico/inmunología , Activación de Linfocitos/efectos de los fármacos , Mitógenos/farmacología , Vitamina A/administración & dosificación
7.
Acta Med Hung ; 45(3-4): 307-11, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3249657

RESUMEN

Treatment with vitamin A (100,000 U daily for 2 weeks) of patients suffering from chronic lymphocytic leukaemia resulted in an enhancement of antibody-dependent cell-mediated cytotoxicity, natural killer cell activity and blastogenic response to plant mitogens.


Asunto(s)
Inmunidad Celular/efectos de los fármacos , Leucemia Linfocítica Crónica de Células B/inmunología , Vitamina A/uso terapéutico , Citotoxicidad Celular Dependiente de Anticuerpos/efectos de los fármacos , Humanos , Células Asesinas Naturales/efectos de los fármacos , Células Asesinas Naturales/inmunología , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Activación de Linfocitos/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA